{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:30:44Z","timestamp":1792643444832,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.xops.2022.100114","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T02:30:18Z","timestamp":1642818618000},"page":"100114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Incidence and Prevalence of Neovascular Age-Related Macular Degeneration in France between 2008 and 2018"],"prefix":"10.1016","volume":"2","author":[{"given":"Catherine P.","family":"Creuzot-Garcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayer","family":"Srour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4976-9876","authenticated-orcid":false,"given":"Florian","family":"Baudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Daien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4398-3978","authenticated-orcid":false,"given":"Corinne","family":"Dot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Nghiem-Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Girmens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Coulombel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4298-328X","authenticated-orcid":false,"given":"Anne","family":"Ponthieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2099-0481","authenticated-orcid":false,"given":"Cecile","family":"Delcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.xops.2022.100114_bib1","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","volume":"9","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.xops.2022.100114_bib2","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1172\/JCI71029","article-title":"Recent developments in the treatment of age-related macular degeneration","volume":"124","author":"Holz","year":"2014","journal-title":"J\u00a0Clin Invest"},{"issue":"10153","key":"10.1016\/j.xops.2022.100114_bib3","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration","volume":"392","author":"Mitchell","year":"2018","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.xops.2022.100114_bib4","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.ophtha.2017.05.035","article-title":"Prevalence of age-related macular degeneration in Europe: the past and the future","volume":"124","author":"Colijn","year":"2017","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.xops.2022.100114_bib5","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.xops.2022.100114_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archophthalmol.2010.318","article-title":"Prevalence of age-related macular degeneration in the US population","volume":"129","author":"Klein","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.xops.2022.100114_bib7","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00417-014-2591-9","article-title":"Prevalence of age-related macular degeneration in a large European cohort: results from the population-based Gutenberg Health Study","volume":"252","author":"Korb","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.xops.2022.100114_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajo.2011.02.004","article-title":"Racial differences in age-related macular degeneration rates in the United States: a longitudinal analysis of a managed care network","volume":"152","author":"Vanderbeek","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.xops.2022.100114_bib9","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.ophtha.2004.01.024","article-title":"Prevalence of lens opacities in Latinos: the Los Angeles Latino Eye Study","volume":"111","author":"Varma","year":"2004","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.xops.2022.100114_bib10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ophtha.2014.08.006","article-title":"Age-related macular degeneration and mortality in community-dwelling elders: the age, gene\/environment susceptibility Reykjavik study","volume":"122","author":"Fisher","year":"2015","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.xops.2022.100114_bib11","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1600-0420.2006.00696.x","article-title":"The prevalence of age-related maculopathy (ARM) in an urban Norwegian population: the Oslo Macular study","volume":"84","author":"Bj\u00f6rnsson","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"issue":"12","key":"10.1016\/j.xops.2022.100114_bib12","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1016\/j.ophtha.2015.08.002","article-title":"The incidence and progression of age-related macular degeneration over 15 years: the Blue Mountains Eye Study","volume":"122","author":"Joachim","year":"2015","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.xops.2022.100114_bib13","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.ophtha.2012.03.016","article-title":"Prevalence of age-related macular degeneration in elderly Caucasians: the Troms\u00f8 Eye Study","volume":"119","author":"Erke","year":"2012","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.xops.2022.100114_bib14","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ophtha.2010.08.044","article-title":"Prevalence of age-related macular degeneration in old persons: Age, Gene\/environment Susceptibility Reykjavik Study","volume":"118","author":"Jonasson","year":"2011","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.xops.2022.100114_bib15","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/bjophthalmol-2011-300304","article-title":"Population-based incidence of exudative age-related macular degeneration and ranibizumab treatment load","volume":"96","author":"Geirsdottir","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.xops.2022.100114_bib16","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/bjophthalmol-2014-305768","article-title":"Prevalence of age-related macular degeneration in the Republic of Ireland","volume":"99","author":"Akuffo","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.xops.2022.100114_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000496393","article-title":"Incidence of age-related macular degeneration in the central region of Portugal: the Coimbra Eye Study\u2014report 5","volume":"61","author":"Farinha","year":"2019","journal-title":"Ophthalmic Res"},{"issue":"8","key":"10.1016\/j.xops.2022.100114_bib18","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archopht.116.8.1031","article-title":"Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Li\u00e9es \u00e0 l\u2019Age","volume":"116","author":"Delcourt","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.xops.2022.100114_bib19","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.ajo.2005.05.002","article-title":"The three-year incidence of age-related macular degeneration: the \u201cPathologies Oculaires Li\u00e9es \u00e0 l\u2019Age\u201d (POLA) prospective study","volume":"140","author":"Delcourt","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.xops.2022.100114_bib20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/jamaophthalmol.2018.0504","article-title":"Incidence of and risk factors associated with age-related macular degeneration: four-year follow-up from the ALIENOR Study","volume":"136","author":"Saunier","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.xops.2022.100114_bib21","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1111\/aos.12842","article-title":"The Montrachet Study: study design, methodology and analysis of visual acuity and refractive errors in an elderly population","volume":"94","author":"Creuzot-Garcher","year":"2016","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"10.1016\/j.xops.2022.100114_bib22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s12603-010-0131-9","article-title":"Nutrition and age-related eye diseases: the Alienor (Antioxydants, Lipides Essentiels, Nutrition et maladies OculaiRes) Study","volume":"14","author":"Delcourt","year":"2010","journal-title":"J\u00a0Nutr Health Aging"},{"issue":"2","key":"10.1016\/j.xops.2022.100114_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.therap.2018.09.072","article-title":"French administrative health care database (SNDS): the value of its enrichment","volume":"74","author":"Scailteux","year":"2019","journal-title":"Therapie"},{"issue":"8","key":"10.1016\/j.xops.2022.100114_bib24","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/pds.4233","article-title":"The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology","volume":"26","author":"Bezin","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"suppl 4","key":"10.1016\/j.xops.2022.100114_bib25","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: from the systeme national d\u2019information interregimes de l\u2019Assurance Maladie (SNIIRAM) to the systeme national des donnees de sante (SNDS) in France","volume":"65","author":"Tuppin","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.xops.2022.100114_bib26","unstructured":"Institut national de la statistique et des \u00e9tudes \u00e9conomiques, the French Offical Statistic Authority (INSEE) FNIoSaES. Demographics bulletin. 2019. INSEE.fr2019. Available at: https:\/\/www.insee.fr\/fr\/statistiques\/4281618"},{"issue":"3","key":"10.1016\/j.xops.2022.100114_bib27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00038-018-1186-3","article-title":"Identifying diabetes cases in health administrative databases: a validation study based on a large French cohort","volume":"64","author":"Fuentes","year":"2019","journal-title":"Int J Public Health"},{"issue":"6","key":"10.1016\/j.xops.2022.100114_bib28","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1016\/j.xops.2022.100114_bib29","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.ophtha.2015.04.017","article-title":"Incidence and characteristics of cataract surgery in France from 2009 to 2012: a national population study","volume":"122","author":"Daien","year":"2015","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.xops.2022.100114_bib30","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/jamaophthalmol.2018.3939","article-title":"Association of acute endophthalmitis with intravitreal injections of corticosteroids or anti-vascular growth factor agents in a nationwide study in France","volume":"136","author":"Baudin","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.xops.2022.100114_bib31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.diabet.2019.12.006","article-title":"Is the type 2 diabetes epidemic plateauing in France? A nationwide population-based study","volume":"46","author":"Fuentes","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.xops.2022.100114_bib32","unstructured":"Institut national de la statistique et des \u00e9tudes \u00e9conomiques, the French Offical Statistic Authority (INSEE). Demographics of French population in 2020. Available at: https:\/\/www.insee.fr\/fr\/statistiques\/5347620"},{"issue":"11","key":"10.1016\/j.xops.2022.100114_bib33","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jamaophthalmol.2014.2333","article-title":"Cardiovascular events and bleeding risk associated with intravitreal antivascular endothelial growth factor monoclonal antibodies: systematic review and meta-analysis","volume":"132","author":"Thulliez","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.xops.2022.100114_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022031","article-title":"Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis","volume":"9","author":"Pham","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.xops.2022.100114_bib35","unstructured":"Direction de la Recherche de L\u2019\u00e9valuation et des Statistiques (DREES). French Health Statistic Department, Health of the French population [L\u2019\u00e9tat de sant\u00e9 de la population en France]. 2015. Available at: https:\/\/drees.solidarites-sante.gouv.fr\/publications\/rapports\/letat-de-sante-de-la-population-en-france-rapport-2015"},{"issue":"5","key":"10.1016\/j.xops.2022.100114_bib36","article-title":"Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study","volume":"149","author":"Varma","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2022.100114_bib37","doi-asserted-by":"crossref","unstructured":"National Research Council (US) Panel on a Research Agenda and New Data for an Aging World. The Health of Aging Populations. In: (US) NAP, ed. Preparing for an Aging World: The Case for Cross-National Research. 2001. Washington, DC: The National Academies Press. Available at: https:\/\/doi.org\/10.17226\/10120.","DOI":"10.17226\/10120"},{"issue":"3","key":"10.1016\/j.xops.2022.100114_bib38","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jalz.2015.11.001","article-title":"Trends in dementia incidence: evolution over a 10-year period in France","volume":"12","author":"Grasset","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.xops.2022.100114_bib39","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.1212\/WNL.0000000000010022","article-title":"Twenty-seven-year time trends in dementia incidence in Europe and the United States: the Alzheimer Cohorts Consortium","volume":"95","author":"Wolters","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.xops.2022.100114_bib40","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1076\/opep.8.4.237.1613","article-title":"Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA Study","volume":"8","author":"Delcourt","year":"2001","journal-title":"Ophthalmic Epidemiol"},{"issue":"7","key":"10.1016\/j.xops.2022.100114_bib41","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/bjo.2010.187773","article-title":"Prevalence of age-related macular degeneration in Spain","volume":"95","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.xops.2022.100114_bib42","first-page":"e442","article-title":"Age-related macular degeneration in Portugal: prevalence and risk factors in a coastal and an inland town. The Coimbra Eye Study\u2014report 2","volume":"94","author":"Cachulo Mda","year":"2016","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"10.1016\/j.xops.2022.100114_bib43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/bjophthalmol-2011-300338","article-title":"Trends over time and geographical variation in rates of intravitreal injections in England","volume":"96","author":"Keenan","year":"2012","journal-title":"Br J Ophthalmol"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914522000033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914522000033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:19:56Z","timestamp":1763014796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914522000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2666914522000033"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2022.100114","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Prevalence of Neovascular Age-Related Macular Degeneration in France between 2008 and 2018","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2022.100114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100114"}}